PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

But the disruption to health funding and the impact on broader services were having a devastating impact on people living with HIV/AIDS, UNAIDS executive director Winnie Byanyima told reporters in ...